US Pharma MarketingSignos raises $20M as it eyes health plan, pharma relationships
Signos, a startup that aims to help people lose weight by understanding their blood sugar, has raised a new $20 million round of funding as it looks beyond its direct-to-consumer roots to employers, health insurers and pharma companies. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the…
Signos, a startup that aims to help people lose weight by understanding their blood sugar, raised $20 million as it looks beyond its direct-to-consumer roots to employers, health insurers and pharma companies.
Palo Alto, CA-based ...
Source: Endpoints News